Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medication
|
| gptkbp:activeDuring |
ivermectin
|
| gptkbp:application |
face
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availability |
prescription only
|
| gptkbp:clinicalTrials |
NCT02212312
NCT02212325 NCT02212338 recommended for rosacea treatment treatment of inflammatory lesions of rosacea |
| gptkbp:contraindication |
allergic reaction
dermatitis swelling redness hypersensitivity to ivermectin |
| gptkbp:dosageForm |
cream
|
| gptkbp:drugInterdiction |
true
antiparasitic agent |
| gptkbp:formulation |
topical cream
|
| gptkbp:hasPopulation |
adults
children over 6 years |
| gptkbp:healthcare |
avoid contact with eyes
apply to clean, dry skin do not use on broken skin |
| gptkbp:historical_analysis |
Comparative effectiveness study
Efficacy in treating rosacea Long-term effects study Patient satisfaction survey Safety profile assessment |
| https://www.w3.org/2000/01/rdf-schema#label |
Soolantra
|
| gptkbp:impact |
up to 12 weeks
|
| gptkbp:lastProduced |
2015
|
| gptkbp:launchSite |
topical application
|
| gptkbp:manufacturer |
Galderma
|
| gptkbp:marketedAs |
gptkb:Canada
gptkb:European_Union gptkb:United_States |
| gptkbp:marketSegment |
ongoing
|
| gptkbp:offers |
varies by pharmacy
|
| gptkbp:packaging |
tube
|
| gptkbp:services |
once daily
|
| gptkbp:sideEffect |
skin irritation
dry skin itching burning sensation |
| gptkbp:storage |
room temperature
|
| gptkbp:triggerType |
reduces inflammation
|
| gptkbp:usedFor |
rosacea
|